During the past decade, UO Ematologia - AOU Policlinico di Modena conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 8 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UO Ematologia - AOU Policlinico di Modena" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 18 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "Gruppo Italiano Trapianto di Midollo Osseo" with 7 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UO Ematologia - AOU Policlinico di Modena" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "Azienda Policlinico Umberto I" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator and "ERIC Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "UO Ematologia - AOU Policlinico di Modena" are "Chronic Lymphocytic Leukemia" (6 trials), "Hematologic Diseases" (3 trials), "Chronic Myeloid Leukemia" (2 trials), "Myelofibrosis" (2 trials) and "Non-Hodgkin's Lymphoma" (2 trials). Many other conditions were trialed in "UO Ematologia - AOU Policlinico di Modena" in a lesser frequency.

Most popular intervention types in "UO Ematologia - AOU Policlinico di Modena" are "Drug" (32 trials), "Other" (4 trials), "Procedure" (3 trials), "Genetic" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (4 trials), "Cyclophosphamide" (3 trials), "Ibrutinib" (3 trials), "Obinutuzumab" (3 trials) and "Venetoclax" (3 trials). Other intervention names were less common.

The vast majority of trials in "UO Ematologia - AOU Policlinico di Modena" are 42 trials for "All" genders.

Currently, there are NaN active trials in "UO Ematologia - AOU Policlinico di Modena". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in UO Ematologia - AOU Policlinico di Modena, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UO Ematologia - AOU Policlinico di Modena, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".